PLANNING COMMITTEE
Marilyn Bull, MD, FAAP, Morris Green Professor Emeritus, Department of Pediatrics, Indiana University School of Medicine; Neurodevelopmental Pediatrician, Riley Hospital for Children
Peter Bulova, MD, Associate Professor of General Internal Medicine; Co-Director, Magee Center for Women with Disabilities; Director, University of Pittsburgh Adult Down Syndrome Center; Director, The Department of Medicine Internal Scholars Track
Brian Chicoine, MD, (Conference Director), Medical Director, Advocate Medical Group Adult Down Syndrome Center; Faculty, Lutheran General Hospital Family Medicine Residency
Katie Frank, PhD, OTR/L, Occupational Therapist III, Advocate Medical Group Adult Down Syndrome Center
Angela Lombardo, BA, Linking Hands Coordinator, Leadership Education in Neurodevelopmental and Related Disabilities (LEND) Family Faculty
Amy Lyle, MSSW, Clinic Coordinator, Waisman Down Syndrome Clinic, University of Wisconsin–Madison
Lina Patel, PsyD, Director of Psychology at the Sie Center for Down Syndrome, Children's Hospital Colorado; Assistant Professor, University of Colorado School of Medicine
Emilie Perkins, Director of Client and Conference Services, Raybourn Group International
Moya Peterson, PhD, APRN, FNP-BC, Adults with Down Syndrome Specialty Clinic, Department of Family Medicine and Community Health, University of Kansas Medical Center
Stephanie Santoro, MD, Clinical Geneticist; Director of Quality Improvement Research, Down Syndrome Program; Assistant in Pediatrics, Harvard Medical School
Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic
Mary Stephens, MD, MPH, FAAFP, FAADM, Medical Director, Jefferson Continuing Care Program (JCCP), Associate Professor, Family and Community Medicine
PROGRAM PRESENTERS
Peter Bulova, MD, Associate Professor of Medicine; Co-Director, Magee Center for Women with Disabilities; Director, University of Pittsburgh Adult Down Syndrome Center
Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center; Faculty, Lutheran General Hospital Family Medicine Residency
Bryn Gelaro, LSW, Senior Director of Adult Initiatives and Special Projects, Global Down Syndrome Foundation
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
NAME | ROLE(s) | FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION? |
Marilyn Bull, MD, FAAP | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Peter Bulova, MD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Brian Chicoine, MD | Course Director, Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Katie Frank, PhD, OTR/L | Committee Member,Speaker | No relevant relationships with ineligible companies to disclose | No |
Bryn Gelaro, LSW | Speaker | No relevant relationships with ineligible companies to disclose | No |
Angela Lombardo, BA | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Amy Lyle, MSSW | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Cathy Means | Planner | No relevant relationships with ineligible companies to disclose | No |
Lina Patel, PsyD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Emilie Perkins | Planner | No relevant relationships with ineligible companies to disclose | No |
Moya Peterson, PhD, APRN | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Stephanie Santoro, MD | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Maria Stanley, MD | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Mary Stephens, MD, MPH | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.